AKT1 and ovarian carcinoma: An ovarian cancer study by He et al. (2019) showed that miR-205 could induce angiogenesis by silencing PTEN and subsequently activates AKT pathway, whereas restoring of PTEN expression can rescue the suppression of angiogenesis induced by the miR-205 inhibitor.